User profiles for A Sigal
 | Alex SigalAHRI Verified email at AHRI.org Cited by 19029 |
Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome
A Sigal, V Rotter - Cancer research, 2000 - AACR
The p53 guardian of the genome is inactivated in the majority of cancers, mostly through
missense mutations that cause single residue changes in the DNA binding core domain of the …
missense mutations that cause single residue changes in the DNA binding core domain of the …
[HTML][HTML] Estimating disease severity of Omicron and Delta SARS-CoV-2 infections
The Omicron variant of SARS-CoV-2 has been reported to cause milder disease in adults
but lead to increased hospital admissions in children. How can we compare disease severity …
but lead to increased hospital admissions in children. How can we compare disease severity …
[HTML][HTML] Milder disease with Omicron: is it the virus or the pre-existing immunity?
A Sigal - Nature Reviews Immunology, 2022 - nature.com
At the population level we are seeing milder disease during the Omicron wave of the SARS-
CoV-2 pandemic. Is this due to the virus or pre-existing immunity, and what should we …
CoV-2 pandemic. Is this due to the virus or pre-existing immunity, and what should we …
Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapy
Latency and ongoing replication 1 have both been proposed to explain the drug-insensitive
human immunodeficiency virus (HIV) reservoir maintained during antiretroviral therapy. …
human immunodeficiency virus (HIV) reservoir maintained during antiretroviral therapy. …
[HTML][HTML] Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
The SARS-CoV-2 Omicron BA.1 variant emerged in 2021 1 and has multiple mutations in its
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …
spike protein 2 . Here we show that the spike protein of Omicron has a higher affinity for …
[HTML][HTML] Efficacy of the ChAdOx1 nCoV-19 Covid-19 vaccine against the B. 1.351 variant
Background Assessment of the safety and efficacy of vaccines against the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …
respiratory syndrome coronavirus 2 (SARS-CoV-2) in different populations is essential, as is …
[HTML][HTML] Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
…, MN Pavlovic, DJ Gregory, MC Poznansky, A Sigal… - Cell, 2021 - cell.com
Vaccination elicits immune responses capable of potently neutralizing SARS-CoV-2. However,
ongoing surveillance has revealed the emergence of variants harboring mutations in …
ongoing surveillance has revealed the emergence of variants harboring mutations in …
[HTML][HTML] Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization
The emergence of the SARS-CoV-2 variant of concern Omicron (Pango lineage B.1.1.529),
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …
first identified in Botswana and South Africa, may compromise vaccine effectiveness and …
[HTML][HTML] T cell responses to SARS-CoV-2 spike cross-recognize Omicron
The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1 , 2 that
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …
Dynamics of the p53-Mdm2 feedback loop in individual cells
… grows with increasing signal. (b) Digital systems show an increased number of pulses
with increasing signal, but the pulse size and shape do not depend on the signal strength. …
with increasing signal, but the pulse size and shape do not depend on the signal strength. …
